<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="29/05/2006" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9178107" creator="Noriko Katsu">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>9178107</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term sem="Organic_compound_other" id="T1" lex="reactive_oxygen_specie">Reactive oxygen species</term> and <term sem="Organic_compound_other" id="T2" lex="antioxidant">antioxidants</term> in <term sem="Other" id="T3" lex="inflammatory_disease">inflammatory diseases</term>.</sentence>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">This paper aims to review the role of <term sem="Inorganic_compound" id="A1">free radical</term>-induced <term sem="Other" id="A2">tissue damage</term> and <term sem="Other" id="A3">antioxidant defence mechanisms</term> in <term sem="Other" id="T4" lex="inflammatory_disease">inflammatory diseases</term> that involve <term sem="Other" id="T5" lex="pathogenic_process">pathogenic processes</term> similar to the <term sem="Other" id="T6" lex="periodontal_disease">periodontal diseases</term>.</sentence>
<event id="E1">
<type class="Positive_regulation" />
<theme idref="A2" />
<cause idref="A1" />
<clue>This paper aims to review the role of free radical-<clueType>induced</clueType> tissue damage and antioxidant defence mechanisms in inflammatory diseases that involve pathogenic processes similar to the periodontal diseases.</clue>
</event>
<event id="E2">
<type class="Regulation" />
<theme idref="T4" />
<cause idref="E1" />
<clue>This paper aims to review the <clueType>role</clueType> <linkCause>of</linkCause> free radical-induced tissue damage and antioxidant defence mechanisms <linkTheme>in</linkTheme> inflammatory diseases that involve pathogenic processes similar to the periodontal diseases.</clue>
</event>
<event id="E3">
<type class="Regulation" />
<theme idref="T4" />
<cause idref="A3" />
<clue>This paper aims to review the <clueType>role</clueType> <linkCause>of</linkCause> free radical-induced tissue damage and antioxidant defence mechanisms <linkTheme>in</linkTheme> inflammatory diseases that involve pathogenic processes similar to the periodontal diseases.</clue>
</event>
<sentence id="S3">There is a clearly defined and substantial role for <term sem="Organic_compound_other" id="T7" lex="free_radical">free radicals</term> or <term sem="Organic_compound_other" id="T8" lex="reactive_oxygen_specie">reactive oxygen species</term> (<term sem="Organic_compound_other" id="T9" lex="ROS">ROS</term>) in <term sem="Tissue_natural" id="T10" lex="periodontitis">periodontitis</term>, but little research has been performed in this area.</sentence>
<event id="E4">
<type class="Regulation" />
<theme idref="T10" />
<cause idref="T7" />
<clue>There is a clearly defined and substantial <clueType>role</clueType> <linkCause>for</linkCause> free radicals or reactive oxygen species (ROS) <linkTheme>in</linkTheme> periodontitis, but little research has been performed in this area.</clue>
</event>
<event id="E5">
<type class="Regulation" />
<theme idref="T10" />
<cause idref="T9" />
<clue>There is a clearly defined and substantial <clueType>role</clueType> <linkCause>for</linkCause> free radicals or reactive oxygen species (ROS) <linkTheme>in</linkTheme> periodontitis, but little research has been performed in this area.</clue>
</event>
<sentence id="S4">This paper reviews the considerable data available relating <term sem="Organic_compound_other" id="T11" lex="ROS">ROS</term> activity and antioxidant defence to <term sem="Other" id="T12" lex="inflammatory_disease">inflammatory diseases</term> and attempts to draw parallels with <term sem="Tissue_natural" id="T13" lex="periodontitis">periodontitis</term>, in an effort to stimulate more periodontal research in this important area.</sentence>
<sentence id="S5">The recent discovery of the <term sem="Protein_complex" id="T14" lex="transcription_factor_nuclear_factor_kappa_B">transcription factor nuclear factor kappa B</term> (<term sem="Protein_complex" id="T15" lex="NF-kappa_B">NF-kappa B</term>) is reviewed and several potential pathways for <term sem="Protein_family_or_group" id="T17" lex="cytokine">cytokine</term>-induced periodontal <term sem="Other" id="A4">tissue damage</term>, mediated by <term sem="Protein_molecule" id="T18" lex="NF-kappa_B1">NF-kappa B1</term> are discussed.</sentence>
<event id="E6">
<type class="Positive_regulation" />
<theme idref="A4" />
<cause idref="T17" />
<clue>The recent discovery of the transcription factor nuclear factor kappa B (NF-kappa B) is reviewed and several potential pathways for cytokine-<clueType>induced</clueType> <clueLoc>periodontal</clueLoc> tissue damage, mediated by NF-kappa B1 are discussed.</clue>
</event>
<event id="E7">
<type class="Positive_regulation" />
<theme idref="E6" />
<cause idref="T18" />
<clue>The recent discovery of the transcription factor nuclear factor kappa B (NF-kappa B) is reviewed and several potential pathways for cytokine-induced periodontal tissue damage, <clueType>mediated</clueType> <linkCause>by</linkCause> NF-kappa B1 are discussed.</clue>
</event>
<sentence id="S6">Emphasis is placed on <term sem="Protein_family_or_group" id="T19" lex="cytokine">cytokines</term> that have been studied in <term sem="Tissue_natural" id="T20" lex="periodontitis">periodontitis</term>, principally <term sem="Protein_molecule" id="T21" lex="TNF-alpha">TNF-alpha</term>, <term sem="Protein_molecule" id="T22" lex="IL-1">IL-1</term>, <term sem="Protein_molecule" id="T23" lex="IL-6">IL-6</term>, <term sem="Protein_molecule" id="T24" lex="IL-8">IL-8</term> and <term sem="Protein_molecule" id="T25" lex="beta-interferon">beta-interferon</term>.</sentence>
<sentence id="S7">The link between cellular production of such important mediators of <term sem="Other" id="T26" lex="inflammation">inflammation</term> and the <term sem="Organic_compound_other" id="T27" lex="antioxidant_(AO)_thiol">antioxidant (AO) thiols</term>, <term sem="Amino_acid_monomer" id="T28" lex="cysteine">cysteine</term> and <term sem="Peptide" id="T29" lex="reduced_glutathione">reduced glutathione</term> (<term sem="Peptide" id="T30" lex="GSH">GSH</term>), is discussed and it is hypothesised that <term sem="Organic_compound_other" id="T31" lex="NF-kappa_B_antagonist"><term sem="Protein_complex" id="T32" lex="NF-kappa_B">NF-kappa B</term> antagonists</term> may offer important <term sem="Other" id="T33" lex="therapeutic_benefit">therapeutic benefits</term>.</sentence>
<event id="E8">
<type class="Gene_expression" />
<theme idref="T21" />
<clue>The link between <clueLoc>cellular</clueLoc> <clueType>production</clueType> <linkTheme>of</linkTheme> <corefTheme>such important mediators of inflammation</corefTheme> and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is discussed and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event id="E9">
<type class="Gene_expression" />
<theme idref="T22" />
<clue>The link between <clueLoc>cellular</clueLoc> <clueType>production</clueType> <linkTheme>of</linkTheme> <corefTheme>such important mediators of inflammation</corefTheme> and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is discussed and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event id="E10">
<type class="Gene_expression" />
<theme idref="T23" />
<clue>The link between <clueLoc>cellular</clueLoc> <clueType>production</clueType> <linkTheme>of</linkTheme> <corefTheme>such important mediators of inflammation</corefTheme> and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is discussed and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event id="E11">
<type class="Gene_expression" />
<theme idref="T24" />
<clue>The link between <clueLoc>cellular</clueLoc> <clueType>production</clueType> <linkTheme>of</linkTheme> <corefTheme>such important mediators of inflammation</corefTheme> and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is discussed and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event id="E12">
<type class="Gene_expression" />
<theme idref="T25" />
<clue>The link between <clueLoc>cellular</clueLoc> <clueType>production</clueType> <linkTheme>of</linkTheme> <corefTheme>such important mediators of inflammation</corefTheme> and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is discussed and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event id="E13">
<type class="Correlation" />
<theme idref="E8" />
<theme idref="T27" />
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is discussed and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event id="E14">
<type class="Correlation" />
<theme idref="E8" />
<theme idref="T28" />
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is discussed and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event id="E15">
<type class="Correlation" />
<theme idref="E8" />
<theme idref="T29" />
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is discussed and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event id="E27">
<type class="Correlation" />
<theme idref="E9" />
<theme idref="T27" />
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is discussed and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event id="E16">
<type class="Correlation" />
<theme idref="E9" />
<theme idref="T28" />
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is discussed and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event id="E17">
<type class="Correlation" />
<theme idref="E9" />
<theme idref="T29" />
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is discussed and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event id="E18">
<type class="Correlation" />
<theme idref="E10" />
<theme idref="T27" />
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is discussed and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event id="E19">
<type class="Correlation" />
<theme idref="E10" />
<theme idref="T28" />
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is discussed and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event id="E20">
<type class="Correlation" />
<theme idref="E10" />
<theme idref="T29" />
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is discussed and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event id="E21">
<type class="Correlation" />
<theme idref="E11" />
<theme idref="T27" />
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is discussed and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event id="E22">
<type class="Correlation" />
<theme idref="E11" />
<theme idref="T28" />
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is discussed and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event id="E23">
<type class="Correlation" />
<theme idref="E11" />
<theme idref="T29" />
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is discussed and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event id="E24">
<type class="Correlation" />
<theme idref="E12" />
<theme idref="T27" />
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is discussed and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event id="E25">
<type class="Correlation" />
<theme idref="E12" />
<theme idref="T28" />
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is discussed and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event id="E26">
<type class="Correlation" />
<theme idref="E12" />
<theme idref="T29" />
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is discussed and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
